News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Iframe sync Post navigation Previous: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories News TODAY SHOW EXPOSES AI MEDICAL SCAMS TARGETING LIPEDEMA PATIENTS Staff December 6, 2025 Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025 Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025
